Genetic decoupling of NINJ1-mediated cell lysis from developmental hydrocephalus reveals the physiological role of the α1 domain

Inside every living cell, a protective skin called the plasma membrane acts as a vital barrier, keeping the cell's internal machinery safe and separate from the outside world. When a cell dies in a specific, violent way known as pyroptosis, this skin is not just damaged; it is shattered. This rupture releases a flood of internal signals that alert the immune system to danger, but it also triggers a chain reaction of inflammation. A protein called NINJ1 sits on the surface of these cells and acts as the master switch for this shattering. Without NINJ1, the membrane stays intact even after the cell has died, preventing the release of those inflammatory signals. Scientists have long wanted to study this process in mice to understand how inflammation drives disease, but there was a major obstacle: mice that completely lack the NINJ1 protein often suffer from a severe brain condition called hydrocephalus, where fluid builds up in the skull, causing many of them to die before they can be used in research. This made it nearly impossible to breed large groups of these mice for big experiments.

A team of researchers at Genentech and the Australian National University has now solved this problem by creating a new type of mouse that behaves like a NINJ1-deficient mouse in its immune response but grows up perfectly healthy. They focused on a specific, small section of the NINJ1 protein, a curved segment near the start of the molecule known as the alpha-1 domain. By making a tiny, precise change to the genetic code of this specific section, they created a mouse that cannot break open its cell membranes when it dies, just like a mouse with no NINJ1 at all. However, unlike the mice with no NINJ1, these new mice develop normally and do not suffer from hydrocephalus. This discovery proves that the part of the protein responsible for breaking open cells is different from the part needed for healthy brain development.

To understand how they achieved this, one must first look at how the NINJ1 protein works. In a healthy, living cell, NINJ1 sits quietly on the surface. When the cell receives a death signal, NINJ1 changes its shape and assembles itself into long, tight chains or filaments. These filaments act like a zipper or a wedge that pries the cell membrane apart, causing it to burst. The researchers knew that a specific amino acid, a building block of the protein, located at position 45 within that alpha-1 domain, was critical for this assembly. In previous experiments using cells grown in a dish, changing this single building block from a lysine to a glutamine stopped the protein from forming the chains needed to rupture the membrane. The team decided to test if this same change would work in a whole living animal.

They used a modern gene-editing tool to introduce this exact change into the DNA of mouse embryos. The result was a line of mice, which they named Ninj1K45Q, that carried this specific mutation on both copies of their gene. When the researchers examined the immune cells from these mice, they found that the cells looked and behaved normally. The NINJ1 protein was present on the surface in the correct amounts. However, when they triggered the cells to die using various methods, such as exposing them to bacterial toxins or chemicals that induce cell death, the cells refused to burst. Instead of rupturing and releasing their contents, the cells simply shrank and remained whole. This confirmed that the mutation successfully disabled the protein's ability to break the membrane, effectively mimicking the effect of having no NINJ1 protein at all.

The researchers then tested whether this mutation affected other related proteins. They looked at NINJ2, a cousin protein that shares a similar structure and sequence. Some earlier studies had suggested that NINJ2 might also play a role in cell rupture, perhaps acting as a backup or a regulator. The team created mice that lacked NINJ2 entirely and found that these mice showed no difference in how their cells ruptured compared to normal mice. Even when they removed both NINJ1 and NINJ2, the cells behaved exactly the same as when only NINJ1 was missing. This ruled out the idea that NINJ2 was helping to break open the cells in these specific immune cells, confirming that NINJ1 is the sole driver of this process in this context.

The true breakthrough, however, came when the researchers looked at the overall health of the mice. Mice that are completely missing the NINJ1 protein have a well-documented problem: about half of them die shortly after birth, and many of the survivors have enlarged heads due to fluid buildup in the brain. This hydrocephalus has been a major bottleneck, preventing scientists from raising the large numbers of mice needed for complex disease studies. When the team examined their new Ninj1K45Q mice, the results were striking. These mice were born in the expected numbers, survived to adulthood, and showed no signs of hydrocephalus or any other developmental abnormalities. Their heads were normal in size and shape.

To ensure this was not just a fluke, the researchers also tested the mice in a model of liver injury. They injected the mice with a substance that causes liver cells to die, a process that normally leads to a massive release of inflammatory signals and liver damage in standard mice. In the new mutant mice, the liver cells died, but because the NINJ1 protein could not break the membrane, the inflammatory signals were not released. Consequently, the liver damage was significantly reduced. This proved that the mutation successfully stopped the inflammatory cascade in a living animal, just as it did in the cells in the dish.

The researchers also created a second type of mutant mouse to test a different part of the protein. They changed a different building block, tryptophan at position 29, which had been previously thought to be involved in how cells stick to one another. These mice, named Ninj1W29A, also grew up healthy without hydrocephalus. However, unlike the first group, their cells still ruptured normally when they died. This told the scientists that the tryptophan at position 29 is not essential for the membrane-breaking function, but the lysine at position 45 is.

These findings allow scientists to finally separate two distinct jobs that NINJ1 performs. One job is to break open the cell membrane to release inflammatory signals, a function that requires the alpha-1 domain and the specific lysine at position 45. The other job is to ensure normal brain development, a function that does not require the membrane-breaking ability but is lost when the entire protein is missing. The new Ninj1K45Q mice possess the broken membrane function but retain the healthy development function. This means researchers can now breed large colonies of these mice to study how cell rupture drives diseases like sepsis, autoimmune disorders, or infections, without worrying that the animals will die from hydrocephalus or that the results will be skewed by developmental defects.

The study also clarified the role of the NINJ2 protein. By showing that mice lacking NINJ2 have no trouble with cell rupture, the researchers provided strong evidence that NINJ2 does not play a significant role in this process in immune cells, at least under the conditions they tested. This helps narrow the focus for future research, suggesting that efforts to understand cell rupture should concentrate on NINJ1.

In the broader picture, this work provides a powerful new tool for the scientific community. For years, the inability to produce large numbers of healthy NINJ1-deficient mice has limited the scope of research into inflammatory diseases. The new mouse model removes this barrier. It allows scientists to study the specific consequences of stopping cell rupture in a living organism, without the confounding factor of developmental brain defects. The researchers have demonstrated that it is possible to genetically uncouple the destructive power of cell rupture from the essential processes of development. This opens the door to more precise investigations into how inflammation works and how it might be controlled, offering a clearer path toward understanding and treating diseases where uncontrolled inflammation causes harm. The work stands as a clear example of how precise genetic engineering can solve a practical problem in research, turning a difficult-to-study biological phenomenon into a manageable and robust experimental system.